Home NDC 67172-595 Clear Eyes Complete 7 Symptom Relief
Product NDC 67172-595
11-digit product format 671720595
Labeler code 67172
Product ID 67172-595_183db81c-7986-4626-88a6-341db9be25ce
Type HUMAN OTC DRUG
Nonproprietary name Hypromellose and Naphazoline Hydrochloride and Polysorbate 80 and Zinc Sulfate
Dosage form LIQUID
Route OPHTHALMIC
Labeler Prestige Brands Holdings, Inc.
Application part349
Marketing category OTC MONOGRAPH FINAL
Marketing start 2010-03-01
Marketing end 0000-00-00
Substance ZINC SULFATE; POLYSORBATE 80; NAPHAZOLINE HYDROCHLORIDE; HYPROMELLOSE
Active strength 1 mL/mL; mL/mL; mL/mL; mL/mL
NDC exclude flag E
Listing certified through 2018-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 40 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 67172-595-01 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 67172-595-01 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 67172-595-01 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 67172-595-01 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 67172-595-01 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 67172-595-01 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 67172-595-01 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 67172-595-01 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 67172-595-01 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 67172-595-01 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 67172-595-01 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 67172-595-01 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 67172-595-01 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2022-08-30 03:57 UTC · source 2022-08-29 excluded product product I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-08-30 03:57 UTC · source 2022-08-29 excluded package package 67172-595-01 I Inactivated by FDA fb8cb913e6d1…eb8c232b6be0…2022-04-09 23:13 UTC · source 2022-04-08 excluded product product I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-09 23:13 UTC · source 2022-04-08 excluded package package 67172-595-01 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 excluded product product I Inactivated by FDA bd6a592717d7…303034d00443…2022-04-04 05:40 UTC · source 2022-04-01 excluded package package 67172-595-01 I Inactivated by FDA bd6a592717d7…303034d00443…2021-12-27 23:28 UTC · source 2021-12-27 excluded product product I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2021-12-27 23:28 UTC · source 2021-12-27 excluded package package 67172-595-01 I Inactivated by FDA 8dfbde2a14a4…c9ff85d89658…2020-12-18 03:04 UTC · source 2020-12-17 excluded product product I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-12-18 03:04 UTC · source 2020-12-17 excluded package package 67172-595-01 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 excluded product product I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2020-06-10 20:45 UTC · source 2020-06-10 excluded package package 67172-595-01 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…2019-12-08 06:16 UTC · source 2019-12-05 excluded product product E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…2019-12-08 06:16 UTC · source 2019-12-05 excluded package package 67172-595-01 E Excluded after deficient or non-compliant submission was not corrected 110d247fa046…a55b01930146…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded HYPROMELLOSE ACTIVE INGREDIENT 3NXW29V3WO CLEAR EYES COMPLETE 7 SYMPTOM RELIEF (HYPROMELLOSE AND NAPHAZOLINE HYDROCHLORIDE AND POLYSORBATE 80 AND ZINC SULFATE) LIQUID [PRESTIGE BRANDS HOLDINGS, INC.] 1 NAPHAZOLINE HYDROCHLORIDE ACTIVE INGREDIENT MZ1131787D CLEAR EYES COMPLETE 7 SYMPTOM RELIEF (HYPROMELLOSE AND NAPHAZOLINE HYDROCHLORIDE AND POLYSORBATE 80 AND ZINC SULFATE) LIQUID [PRESTIGE BRANDS HOLDINGS, INC.] 1 POLYSORBATE 80 ACTIVE INGREDIENT 6OZP39ZG8H CLEAR EYES COMPLETE 7 SYMPTOM RELIEF (HYPROMELLOSE AND NAPHAZOLINE HYDROCHLORIDE AND POLYSORBATE 80 AND ZINC SULFATE) LIQUID [PRESTIGE BRANDS HOLDINGS, INC.] 1 ZINC SULFATE ACTIVE INGREDIENT 89DS0H96TB CLEAR EYES COMPLETE 7 SYMPTOM RELIEF (HYPROMELLOSE AND NAPHAZOLINE HYDROCHLORIDE AND POLYSORBATE 80 AND ZINC SULFATE) LIQUID [PRESTIGE BRANDS HOLDINGS, INC.] 1 HYPROMELLOSE ACTIVE MOIETY 3NXW29V3WO CLEAR EYES COMPLETE 7 SYMPTOM RELIEF (HYPROMELLOSE AND NAPHAZOLINE HYDROCHLORIDE AND POLYSORBATE 80 AND ZINC SULFATE) LIQUID [PRESTIGE BRANDS HOLDINGS, INC.] 1 NAPHAZOLINE ACTIVE MOIETY H231GF11BV CLEAR EYES COMPLETE 7 SYMPTOM RELIEF (HYPROMELLOSE AND NAPHAZOLINE HYDROCHLORIDE AND POLYSORBATE 80 AND ZINC SULFATE) LIQUID [PRESTIGE BRANDS HOLDINGS, INC.] 1 POLYSORBATE 80 ACTIVE MOIETY 6OZP39ZG8H CLEAR EYES COMPLETE 7 SYMPTOM RELIEF (HYPROMELLOSE AND NAPHAZOLINE HYDROCHLORIDE AND POLYSORBATE 80 AND ZINC SULFATE) LIQUID [PRESTIGE BRANDS HOLDINGS, INC.] 1 ZINC ACTIVE MOIETY J41CSQ7QDS CLEAR EYES COMPLETE 7 SYMPTOM RELIEF (HYPROMELLOSE AND NAPHAZOLINE HYDROCHLORIDE AND POLYSORBATE 80 AND ZINC SULFATE) LIQUID [PRESTIGE BRANDS HOLDINGS, INC.] 1 CALCIUM CHLORIDE INACTIVE INGREDIENT M4I0D6VV5M CLEAR EYES COMPLETE 7 SYMPTOM RELIEF (HYPROMELLOSE AND NAPHAZOLINE HYDROCHLORIDE AND POLYSORBATE 80 AND ZINC SULFATE) LIQUID [PRESTIGE BRANDS HOLDINGS, INC.] 1 CITRIC ACID INACTIVE INGREDIENT 2968PHW8QP CLEAR EYES COMPLETE 7 SYMPTOM RELIEF (HYPROMELLOSE AND NAPHAZOLINE HYDROCHLORIDE AND POLYSORBATE 80 AND ZINC SULFATE) LIQUID [PRESTIGE BRANDS HOLDINGS, INC.] 1 EDETATE DISODIUM INACTIVE INGREDIENT 7FLD91C86K CLEAR EYES COMPLETE 7 SYMPTOM RELIEF (HYPROMELLOSE AND NAPHAZOLINE HYDROCHLORIDE AND POLYSORBATE 80 AND ZINC SULFATE) LIQUID [PRESTIGE BRANDS HOLDINGS, INC.] 1 MAGNESIUM CHLORIDE INACTIVE INGREDIENT 02F3473H9O CLEAR EYES COMPLETE 7 SYMPTOM RELIEF (HYPROMELLOSE AND NAPHAZOLINE HYDROCHLORIDE AND POLYSORBATE 80 AND ZINC SULFATE) LIQUID [PRESTIGE BRANDS HOLDINGS, INC.] 1 POTASSIUM CHLORIDE INACTIVE INGREDIENT 660YQ98I10 CLEAR EYES COMPLETE 7 SYMPTOM RELIEF (HYPROMELLOSE AND NAPHAZOLINE HYDROCHLORIDE AND POLYSORBATE 80 AND ZINC SULFATE) LIQUID [PRESTIGE BRANDS HOLDINGS, INC.] 1 SODIUM CHLORIDE INACTIVE INGREDIENT 451W47IQ8X CLEAR EYES COMPLETE 7 SYMPTOM RELIEF (HYPROMELLOSE AND NAPHAZOLINE HYDROCHLORIDE AND POLYSORBATE 80 AND ZINC SULFATE) LIQUID [PRESTIGE BRANDS HOLDINGS, INC.] 1 SODIUM CITRATE INACTIVE INGREDIENT 1Q73Q2JULR CLEAR EYES COMPLETE 7 SYMPTOM RELIEF (HYPROMELLOSE AND NAPHAZOLINE HYDROCHLORIDE AND POLYSORBATE 80 AND ZINC SULFATE) LIQUID [PRESTIGE BRANDS HOLDINGS, INC.] 1 SORBIC ACID INACTIVE INGREDIENT X045WJ989B CLEAR EYES COMPLETE 7 SYMPTOM RELIEF (HYPROMELLOSE AND NAPHAZOLINE HYDROCHLORIDE AND POLYSORBATE 80 AND ZINC SULFATE) LIQUID [PRESTIGE BRANDS HOLDINGS, INC.] 1 WATER INACTIVE INGREDIENT 059QF0KO0R CLEAR EYES COMPLETE 7 SYMPTOM RELIEF (HYPROMELLOSE AND NAPHAZOLINE HYDROCHLORIDE AND POLYSORBATE 80 AND ZINC SULFATE) LIQUID [PRESTIGE BRANDS HOLDINGS, INC.] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 67172-595 CLEAR EYES COMPLETE 7 SYMPTOM RELIEF (HYPROMELLOSE AND NAPHAZOLINE HYDROCHLORIDE AND POLYSORBATE 80 AND ZINC SULFATE) LIQUID [PRESTIGE BRANDS HOLDINGS, INC.] 1 Legacy NDC 20100820_9a1ce5e2-c3da-424d-b754-cf2de8c655e3.zip